PfNCR1 Transporter: A Target for Antimalarial Drugs
Author Information
Author(s): Zhang Zhemin, Lyu Meinan, Han Xu, Bandara Sepalika, Cui Meng, Istvan Eva S., Geng Xinran, Tringides Marios L., Gregor William D., Miyagi Masaru, Oberstaller Jenna, Adams John H., Zhang Youwei, Nieman Marvin T., von Lintig Johannes, Goldberg Daniel E., Yu Edward W.
Primary Institution: Department of Pharmacology, Case Western Reserve University School of Medicine
Hypothesis
The PfNCR1 transporter is essential for cholesterol export in Plasmodium falciparum and could be targeted for antimalarial drug development.
Conclusion
PfNCR1 is capable of exporting cholesterol from the parasite's plasma membrane, making it a promising target for new antimalarial therapies.
Supporting Evidence
- PfNCR1 was shown to bind cholesterol and form a transport tunnel.
- Cholesterol efflux assays indicated that PfNCR1 can export cholesterol from the membrane.
- MMV009108 inhibits PfNCR1, blocking cholesterol transport.
Takeaway
PfNCR1 helps the malaria parasite get rid of cholesterol, which is important for its survival, and blocking this transporter could help fight malaria.
Methodology
The study used single-particle cryo-electron microscopy to determine the structure of the PfNCR1 transporter and conducted cholesterol efflux assays.
Limitations
The study primarily focuses on structural insights and may not fully address the in vivo implications of PfNCR1 inhibition.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website